Read the latest news about HTG’s CDx plans and other alliances!

While initially caught off-guard by Qiagen's decision to nix its next-generation clinical sequencer development activities, which derailed an important alliance for the firm, HTG Molecular Diagnostics is now focusing its energies on a whole-transcriptome panel developed in house and companion diagnostic alliances.